← Evidence map

ReviewNature reviews. Rheumatology2024

The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout.

Chio Yokose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38472344